戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 significantly increased with reinfection and active immunization.
2 successful strategy to develop a vaccine for active immunization.
3  autoimmune encephalomyelitis independent of active immunization.
4 b titers define protection in the setting of active immunization.
5 ular effectors in the neutropenic host after active immunization.
6 opriate serologic testing and counseling for active immunization.
7 , significantly enhanced T cell responses to active immunization.
8 valuate potential vaccine candidates through active immunization.
9 tion was enhanced in SCI rats via passive or active immunization.
10 e quality of immune responses induced during active immunizations.
11 ng antibody responses, whether by passive or active immunization, a genotyping monitor will be necess
12  evaluated the basis for immunity induced by active immunization against a melanoma differentiation A
13 tive tumor immunity in models of passive and active immunization against a relevant tumor differentia
14                                   Successful active immunization against cancer requires induction of
15 that CSL is a rational target for passive or active immunization against cryptosporidiosis.
16  a candidate molecular target for passive or active immunization against cryptosporidiosis.
17                                              Active immunization against F/FA and other opioids repre
18 assive immunization with mAb against gp75 or active immunization against gp75 prevented the developme
19 ivable that an immunomodulatory strategy via active immunization against many of these antigens could
20 rpose of this study was to determine whether active immunization against pneumolysin (PLY), or polysa
21 w observations on the results of passive and active immunization against the antigens.
22                                              Active immunization against the beta-amyloid peptide (Al
23                                              Active immunization against the tumor-specific MAGE-A3 a
24 eventual expression of cancer Ags by LCs for active immunization against tumors.
25                    Our data demonstrate that active immunization against VIP reduces neuronal recruit
26 e of the newly characterized oligomers as an active immunization agent targeting amyloid self- assemb
27 n wild-type mice an alternative approach for active immunization: an epitope vaccine that selectively
28                                              Active immunization and adoptive transfer EAE models wer
29 educed the duration and clinical severity of active immunization and adoptive transfer EAE.
30  early effector T cells, in combination with active immunization and IL-2, resulted in the eradicatio
31 fficacy of recombinant PotD was evaluated by active immunization and intravenous challenge with capsu
32                               Recently, both active immunization and passive administration of A beta
33 he selection of immunogens as candidates for active immunization and vice versa.
34 We address these controversies and summarize active-immunization and passive-immunization experiments
35  mice are highly resistant to EAE induced by active immunization, and this resistance appears to be m
36                      Here, using passive and active immunization approaches in wild-type and FcgammaR
37 ing viral antigens may be useful for in vivo active immunization as well as ex vivo priming of cytoto
38 ollowing primary infection, reinfection, and active immunization, as well as immune protection in mic
39 e receptor (CCR)2, did not develop EAE after active immunization but generated effector cells that co
40               We conclude that CD28 licenses active immunization by regulating Ag-induced immunoregul
41                                              Active immunization can be performed using either the im
42 e in BMT patients is the first evidence that active immunization can reduce morbidity due to herpesvi
43 virus-neutralizing antibodies, together with active immunization, can prevent development of the dise
44                                        After active immunization, clinical scores of corneas of the r
45 cells, or two injections 7 and 10 days after active immunization, completely blocked development of E
46 vity with anti-IgE autoantibodies induced by active immunization could potentially offer an efficient
47 ired antibody following primary infection or active immunization demonstrated no significant alterati
48 Anti-TECK Ab, elicited in the female mice by active immunization, depleted the ovarian CD8alpha alpha
49                             As we found with active-immunization EAE, neuroinflammation was greatly r
50 f SasX as a vaccine component in passive and active immunization efforts using mouse infection models
51  In immunoblots, sera from rabbits following active immunization elicited cross-reactive antibodies t
52                                           In active immunization experiments, 78% of mice immunized w
53                                              Active immunization for hepatitis B virus (HBV) infectio
54 ntrast, engagement of OX40 in the setting of active immunization has potent adjuvant properties, lead
55          Finally, immunity can persist after active immunizations have ended.
56                                        After active immunization, high levels of protection were achi
57 y of disease were dramatically reduced after active immunization in complement-depleted rats.
58 ndritic cells (DC) as a cellular vaccine for active immunization in healthy volunteers and allogeneic
59                         Here, we reveal that active immunization in mice with NDV-3A induces high tit
60            Little is known about the role of active immunization in suppressing undesirable immune re
61  of inducing tumor-specific immunity through active immunization in the absence of defined tumor-asso
62 opM was not protective, either by passive or active immunization, in inbred or outbred mice.
63 nhibition assays, passive immunizations, and active immunizations indicated that this outer membrane-
64                                              Active immunization is an essential pillar to prevent SA
65 from mucosal SIV challenge in the setting of active immunization is more complex than previously reco
66                                   Rationale: Active immunization is needed to protect infants and you
67                     Induction of EAE through active immunization led to rapid and severe disease in a
68                               We report that active immunization markedly reduces intracellular Abeta
69                                       In the active immunization model of experimental autoimmune enc
70  and complete Freund's adjuvant (CFA)-evoked active immunization models compared to the reference SSA
71        The first was homogeneous, capable of active immunization (mouse intravenous 50% lethal dose,
72                                              Active immunization of AG6 mice with a modified DENV NS1
73                                              Active immunization of at-risk neighborhoods may be nece
74        Together, these studies indicate that active immunization of cancer-prone individuals may resu
75                                              Active immunization of hamsters with E. coli membrane fr
76 suggest that intervention strategies such as active immunization of human immunodeficiency virus (HIV
77 to improve DC-based immunotherapy; i.e., the active immunization of humans with autologous DCs that h
78 oxidized low-density lipoprotein (oxLDL) and active immunization of hypercholesterolemic mice with ox
79                We have shown previously that active immunization of mice against the melanocyte diffe
80                                              Active immunization of mice with a combination of the A
81                                              Active immunization of mice with combinations of PNAG an
82                                              Active immunization of mice with liposomal complete-core
83 potential role in host-pathogen interaction, active immunization of mice with recombinant enolase fai
84                                              Active immunization of murine dams with GBS6 prior to ma
85                                              Active immunization of PDAPP mice with human amyloid bet
86                   We studied the capacity of active immunization of rhesus monkeys with HIV-1 envelop
87 n (PLP) 139--151-specific T cells engaged by active immunization of SJL mice.
88  to address the effects of anti-amyloid-beta active immunization on neurite trajectories and the path
89 lenge, but there was no detectable effect of active immunization once the tumor was established.
90  optimal formulation of either a vaccine for active immunization or a polyclonal intravenous IgG or m
91 at S. aureus type 5 CP antibodies induced by active immunization or administered by passive immunizat
92 c T cells, either spontaneously or following active immunization or adoptive transfer, immune-mediate
93 potential of PNAG as a vaccine component for active immunization or as a target for passive antibody
94 ce with MP4 after induction of EAE either by active immunization or by adoptive transfer of activated
95 antibodies may be most efficacious following active immunization or passive administration.IMPORTANCE
96 f this Ab in mice, as a result of passive or active immunization, or by enforced expression of the SM
97 ivation can be elicited in viral infections, active immunization, or cancer immunotherapy, leading to
98  IL-6 deficiency in models of EAE induced by active immunization, passive transfer, T cell transfer,
99 ce of maternal antibody also interferes with active immunization, placing infants at risk for severe
100               Antibodies, through passive or active immunization, play a central role in prophylaxis
101                                  Passive and active immunization protected mice from pneumococcal car
102 ation of efficacy is important in support of active immunization protocols as therapy for, or potenti
103 nical response of cancer patients undergoing active immunization protocols.
104                                 Furthermore, active immunization reduced acute lung injury in a lung
105        Three separate studies, two involving active-immunization regimens and one involving a passive
106       In contrast, tumor immunity induced by active immunization requires Ag receptor-bearing CD4+ T
107                                              Active immunization resulted in higher serological total
108                                              Active immunization schedules are being developed to min
109      Together, these data reveal passive and active immunization strategies for prevention or therapy
110                  There is an urgent need for active immunization strategies that, if administered sho
111                                     Thus, an active immunization strategy that targets an angiogenesi
112   Here, we show the beneficial effects of an active immunization strategy using the SEDI antigenic pe
113                                       Recent active immunization studies have raised the possibility
114                              Our passive and active immunization studies in mice suggest that Fc-Fcga
115  the inter-species cytokine as immunogen for active immunization (TISCAI) to induce anti-cytokine ant
116                Here, we investigated whether active immunization to promote clearance of Abeta from a
117  the combination strategy using passive plus active immunization to provide protection of infants bor
118 PLP) 139-151 peptide EAE model, we show that active immunizations using CFA but not CpG 1826/IFA as a
119    One notable difference from GN induced by active immunization was a T cell infiltration in the ren
120                               In this study, active immunization was studied in neutropenic rats infe
121                 Unlike passive immunization, active immunization, which is the foundation of vaccinol
122 everity, or histopathology of EAE induced by active immunization with 100 micro g of myelin oligodend
123  monoclonal antibody GNC92H2 was elicited by active immunization with a cocaine immunoconjugate and b
124                                              Active immunization with a mutant form of Hla (Hla(H35L)
125                                              Active immunization with a native preparation of HgbA (n
126 e immunization with Hla-specific antisera or active immunization with a nontoxigenic form of Hla sign
127                        Here, we present that active immunization with a phosphorylated tau epitope, i
128 cal, and immununological responses following active immunization with a purified Porphyromonas gingiv
129                       A clinical trial using active immunization with Abeta1-42 was suspended after a
130 immunotherapy for human Alzheimer's disease, active immunization with amyloid-beta 1-42 results in th
131                               In conclusion, active immunization with an anti-endotoxin vaccine impro
132  in combination with existing medications is active immunization with antiopioid vaccines, which stim
133        Chronic serum sickness was induced by active immunization with apoferritin.
134 ntine leukocidin (PVL), we evaluated whether active immunization with attenuated forms of Hla (HlaH35
135                       Animal models based on active immunization with bacterial or viral mimics, dire
136                                              Active immunization with CFA and pertussis toxin, a proc
137                                              Active immunization with conjugated types 5 and 8 capsul
138 iated mortality were effectively reversed by active immunization with dendritic cells treated with HM
139                                              Active immunization with DJ NS1 induced a strong Ab resp
140 treptococcal pyrogenic exotoxin A (SpeA), or active immunization with either wild-type or a nonfuncti
141 of murine WN virus infection, and the use of active immunization with envelope protein and passive tr
142                                              Active immunization with Escherichia coli-expressed reco
143                     These data indicate that active immunization with genes encoding tumor-specific a
144                                              Active immunization with GNC-KLH produced approximately
145                                              Active immunization with GND-KLH produced a 76% decrease
146 lerated in a chronic serum sickness model by active immunization with heterologous apoferritin.
147                                              Active immunization with HMW-MAA mimics has been previou
148                                              Active immunization with homologous, but not heterologou
149 perimental autoimmune uveoretinitis (EAU) by active immunization with interphotoreceptor retinal bind
150 s and the protective efficacy of passive and active immunization with J5 vaccine against experimental
151                     These data indicate that active immunization with LOS-based conjugates reduces th
152                                              Active immunization with M1 Sse significantly protects m
153 y Neisseria meningitidis can be prevented by active immunization with meningococcal polysaccharide or
154                                 Importantly, active immunization with MHC class II(+) APCs triggered
155                                              Active immunization with MntC was effective at reducing
156 toimmune encephalomyelitis (EAE) produced by active immunization with myelin oligodendrocyte glycopro
157                        Upon EAE induction by active immunization with myelin oligodendrocyte glycopro
158                                              Active immunization with nontoxigenic Hla(H35L) or passi
159                                              Active immunization with OMVs or passive transfer of ser
160                  These data demonstrate that active immunization with P6 results in the production of
161 rosinase-related protein-1 (Tyrp1; gp75) and active immunization with plasmid DNA encoding altered Ty
162 AICAR), in active and passive EAE induced by active immunization with PLP(139-151) or MOG(35-55) and
163                                              Active immunization with pneumococcal capsular polysacch
164  of ligature-induced periodontitis, and that active immunization with porphypain-2 appeared capable o
165                                              Active immunization with Porphyromonas gingivalis whole-
166                 The prophylactic efficacy of active immunization with purified P. aeruginosa LPS was
167 ge and no evidence of protection afforded by active immunization with purified pilin.
168  created an experimental mouse model through active immunization with recombinant murine nephrin.
169                                              Active immunization with recombinant P21 did not protect
170                                              Active immunization with recombinant SasX or passive imm
171      In a genetically humanized mouse model, active immunization with sE2 efficiently protected again
172                                              Active immunization with Streptococcus mutans glucan bin
173                                              Active immunization with the amyloid beta (A beta) pepti
174                                              Active immunization with the BNT162b2 vaccine (Pfizer-Bi
175 e present study investigated the efficacy of active immunization with the C-terminal domain of alpha
176                              The efficacy of active immunization with the cocaine immunogen GNC-keyho
177 neumococcal keratitis in the rabbit, whereas active immunization with the conserved protein virulence
178                                              Active immunization with the first 50 amino acids of the
179          Here, we tested the hypothesis that active immunization with the idiotype would evoke a poly
180  experimental autoimmune uveoretinitis after active immunization with the interphotoreceptor retinoid
181                                              Active immunization with this vaccine merits further inv
182                  The alternative approach of active immunization with tumor Id can cure the disease i
183                             We conclude that active immunization with tumor Id can induce a polyclona
184 charide (CP)-specific antibodies elicited by active immunization with vaccines composed of Staphyloco
185      Four groups of infant macaques received active immunizations with subunit Env protein or modifie
186 ll mice were markedly resistant to EAE after active immunization, with drastically impaired recruitme

 
Page Top